These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 23226373)
1. FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx. Dutra RL; de Carvalho MB; Dos Santos M; Mercante AM; Gazito D; de Cicco R; Group G; Tajara EH; Louro ID; da Silva AM PLoS One; 2012; 7(11):e50747. PubMed ID: 23226373 [TBL] [Abstract][Full Text] [Related]
2. FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma. Koole K; van Kempen PM; van Bockel LW; Smets T; van der Klooster Z; Dutman AC; Peeters T; Koole R; van Diest P; van Es RJ; Willems SM Pathobiology; 2015; 82(6):280-9. PubMed ID: 26551585 [TBL] [Abstract][Full Text] [Related]
3. ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma. Choi KY; Rho YS; Kwon KH; Chung EJ; Kim JH; Park IS; Lee DJ Cancer Biomark; 2012-2013; 12(3):115-24. PubMed ID: 23481570 [TBL] [Abstract][Full Text] [Related]
4. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538 [TBL] [Abstract][Full Text] [Related]
5. FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma. Tanuma J; Izumo T; Hirano M; Oyazato Y; Hori F; Umemura E; Shisa H; Hiai H; Kitano M Oncol Rep; 2010 Mar; 23(3):739-44. PubMed ID: 20127014 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement. Quintanal-Villalonga Á; Carranza-Carranza A; Meléndez R; Ferrer I; Molina-Pinelo S; Paz-Ares L Clin Lung Cancer; 2017 Nov; 18(6):667-674.e1. PubMed ID: 28583379 [TBL] [Abstract][Full Text] [Related]
7. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression. Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967 [TBL] [Abstract][Full Text] [Related]
8. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma. Streit S; Bange J; Fichtner A; Ihrler S; Issing W; Ullrich A Int J Cancer; 2004 Aug; 111(2):213-7. PubMed ID: 15197773 [TBL] [Abstract][Full Text] [Related]
10. The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma. da Costa Andrade VC; Parise O; Hors CP; de Melo Martins PC; Silva AP; Garicochea B Exp Mol Pathol; 2007 Feb; 82(1):53-7. PubMed ID: 17084840 [TBL] [Abstract][Full Text] [Related]
11. FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition. Ye Y; Li J; Jiang D; Li J; Xiao C; Li Y; Han C; Zhao C Cancer Res Treat; 2020 Oct; 52(4):1162-1177. PubMed ID: 32599983 [TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas. Wimmer E; Ihrler S; Gires O; Streit S; Issing W; Bergmann C World J Clin Oncol; 2019 Mar; 10(3):136-148. PubMed ID: 30949443 [TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma. Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919 [TBL] [Abstract][Full Text] [Related]
14. Is FGFR4 Gly388Arg missense variant a suitable prognostic marker in neuroblastoma? Katarzyna S J Cancer Res Ther; 2023; 19(2):355-358. PubMed ID: 37006072 [TBL] [Abstract][Full Text] [Related]
15. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor. Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients. Shen YY; Lu YC; Shen DP; Liu YJ; Su XY; Zhu GS; Yin XL; Ni XZ World J Gastroenterol; 2013 Jul; 19(28):4568-75. PubMed ID: 23901234 [TBL] [Abstract][Full Text] [Related]
17. FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls. Xu B; Tong N; Chen SQ; Hua LX; Wang ZJ; Zhang ZD; Chen M BMC Cancer; 2011 Feb; 11():84. PubMed ID: 21349172 [TBL] [Abstract][Full Text] [Related]
18. Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. Huber GF; Züllig L; Soltermann A; Roessle M; Graf N; Haerle SK; Studer G; Jochum W; Moch H; Stoeckli SJ BMC Cancer; 2011 Jun; 11():217:1-8. PubMed ID: 21639893 [TBL] [Abstract][Full Text] [Related]
19. Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension. Al-Daghri NM; Mohammed AK; Al-Attas OS; Draz HM; Alokail MS Genet Test Mol Biomarkers; 2017 Jul; 21(7):422-427. PubMed ID: 28650667 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum liver enzymes in oral and oropharynx squamous cell carcinomas. Zhu Z; Zhou J; Xiong X; Liu D; Zheng Y; Ding X; Du Y; Gu N; Wu Y; Song X J Oral Pathol Med; 2019 Jan; 48(1):36-42. PubMed ID: 30447114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]